Draegerwerk AG KGaA's EBIT per Share for the
three
months ended in Mar. 2026 was CHF1.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was CHF13.25.
During the past 12 months, the average EBIT per Share Growth Rate of Draegerwerk AG KGaA was 51.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Draegerwerk AG KGaA's EBIT per Share or its related term are showing as below:
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Draegerwerk AG KGaA was 60.10% per year. The lowest was -31.20% per year. And the median was -6.80% per year.
XSWX:DRW3's 3-Year EBIT Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9.5 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Draegerwerk AG KGaA (XSWX:DRW3) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Draegerwerk AG KGaA EBIT per Share Related Terms
Draegerwerk AG KGaA EBIT per Share Historical Data
* Premium members only.
The historical data trend for Draegerwerk AG KGaA's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF13.25
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Draegerwerk AG KGaA (XSWX:DRW3) has a EBIT per Share of CHF13.25 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Draegerwerk AG KGaA and its competitors. According to the industry distribution chart, Draegerwerk AG KGaA ranks #999999 out of 688 companies in the Medical Devices & Instruments industry.
Is Draegerwerk AG KGaA's EBIT per Share too high?
Draegerwerk AG KGaA's current EBIT per Share is CHF13.25. Based on the distribution chart, Draegerwerk AG KGaA ranks #999999 out of 688 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Draegerwerk AG KGaA has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Draegerwerk AG KGaA's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Draegerwerk AG KGaA ranks #999999 out of 688 companies for EBIT per Share. This places Draegerwerk AG KGaA in the lower half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Draegerwerk AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Draegerwerk AG KGaA's current EBIT per Share is CHF13.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Draegerwerk AG KGaA stock overvalued right now?
Draegerwerk AG KGaA (XSWX:DRW3) has a current EBIT per Share of CHF13.25. The stock's GF Value™ is CHF54.56, compared to a current price of CHF78.20 — trading 43.3% above its estimated fair value. The current EBIT per Share is CHF13.25. Draegerwerk AG KGaA's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Draegerwerk AG KGaA (XSWX:DRW3), the current EBIT per Share is CHF13.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Draegerwerk AG KGaA (XSWX:DRW3) Overvalued in 2026?
Based on GuruFocus' analysis, Draegerwerk AG KGaA stock appears to be overvalued.
The current stock price of CHF78.20 is trading 43.3% above its estimated GF Value™ of CHF54.56.
Key valuation signals for XSWX:DRW3:
EBIT per Share: CHF13.25
GF Value™: CHF54.56 vs. price of CHF78.20 (43.3% above fair value)
No single metric tells the full story. See the XSWX:DRW3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
75GF Score
Get the complete analysis for XSWX:DRW3
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DRW3 has been successfully added to your 
